[1]. Zaman M, Ahmad E, Qadeer A, Rabbani G, Khan RH. Nanoparticles in relation to peptide and protein aggregation. Int J Nanomed. 2014; 9: 899–912.
[2]. Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005; 172: 1487–1490.
[3]. Chiang YD, Lian HY, Leo S-Y, Wang S-G, Yamauchi Y, Wu KCW. Controlling particle size and structural properties of mesoporous silica nanoparticles using the taguchi method. J PhysChem C. 2011; 115: 1358–13165.
[4]. Zainala NA, Shukor SRA, Wab SRA, Razak KA. Study on the effect of synthesis parameters of silica nanoparticles entrapped with rifampicin. AIDIC Conf Ser. 2013; 11; 431– 440.
[5]. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353.
[6]. Tatini F, Pugliese AM, Traini C, Niccoli S, Maraula G, Ed Dami T, Mannini B, Scartabelli T, Pedata F, Casamenti F, Chiti F. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N. Neurobiol Aging 2013;34:2100-9.
[7]. Brambilla D, Verpillot R, Le Droumaguet B, Nicolas J, Taverna M, Kona J. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease. ACS Nano 2012; 6: 5897-908.
[8]. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and micro vascular disease- systematic review and metaanalysis. Neurobiol Aging 2009; 30: 337-352.
[9]. Gladytz A, Abel B, Risselada HJ. Gold-Induced Fibril Growth: The Mechanism of Surface-Facilitated Amyloid Aggregation. Angew Chem Int Ed Engl. 2016; 55: 11242-6.
[10]. Mahmoudi M, Hosseinkhani H, Hosseinkhani M, et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev. 2011;111: 253–280.
[11]. Padmanabhan P, Kumar A, Kumar S, Chaudhary RK, Gulyas B. Nanoparticles in practice for molecular-imaging applications: an overview. Acta Biomater. 2016; 41: 1–16.
[12]. Ramshini H, Moghaddasi AS, Aldaghi LS, Mollania N, Ebrahim-Habibi A. Arch Ital Biol. 2017; 155: 131-141
[13]. Ramshini H, Moghaddasi AS, Mollania N, Khodarahmi R. Diverse antithetical effects of the bio-compatible Ag-NPs on the hen egg lysozyme amyloid aggregation: from an efficient inhibitor to obscure inducer Journal of the Iranian Chemical Society. J Iran Chem Society 2019; 16: 33-44
[14]. Vural H, Demirin H, Kara Y, Eren I, Delibas N. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol. 2010; 24:169-173.
[15]. Rita Cardoso B, Silva Bandeira V, Jacob-Filho W, FranciscatoCozzolino SM. Selenium status in elderly, relation to cognitive decline. J Trace Elem Med Biol. 2014; 28: 422-426.
[16]. Kosik KS. Alzheimer’s disease, a cell biological perspective. Science 1992; 256:780-783.
[17]. Nazıroğlu M, Muhamad S, Pecze L. Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles. Expert Rev Clin Pharmacol. 2017; 10: 773-782. [18]. Toshima N, Yonezawa T. Bimetallic nanoparticles-novel materials for chemical and physical applications. New J Chem. 1998; 22: 1179–1201.
[19]. Mesbahi-Nowrouzi M, Mollania M. Purification of selenite reductase from Alcaligenes sp. CKCr-6A with the ability to biosynthesis of selenium nanoparticle: Enzymatic behavior study in imidazolium based ionic liquids and organic solvent. J Mol Liquids 2018; 249: 1254–1262
[20]. Ramshini H, mohammad-zadeh M, Ebrahim-Habibi A. Inhibition of amyloid fibril formation and cytotoxicity by a chemical analog of Curcumin as a stable inhibitor. Int J Biol Macromol. 2015; 78: 396-404.
[21]. Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods 2004; 34: 151-60.
[22]. Selkoe DJ. Folding proteins in fatal ways Nature 2004; 25,:428, 445.
[23]. Iravani, S. Green synthesis of metal nanoparticles using plants. Green Chem. 2011; 13: 2638-2650. [24]. Mittal A K, Chisti Y, Banerjee UC. Synthesis of metallic nanoparticles using plant extracts. Biotechnol. Adv. 2013; 31: 346-356.
[25]. Gao J, Ren, X, Chen, D, Tang F, Ren J. Bimetallic Ag–Pt hollow nanoparticles: Synthesis and tunable surface Plasmon resonance. Scr. Mater. 2007; 57: 687–690.
[26]. Sun S, Murray CB, Weller D, Folks L, Moser A. Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 2000; 287: 1989–1992
[27]. Vongsavat V, Vittur BM, Bryan WW, Kim J-H, Lee TR. Ultrasmall hollow gold–silver nanoshells with extinctions strongly red-shifted to the near-infrared. ACS Appl Mater Interfaces 2011; 3: 3616–3624. [28]. Sra AK, Schaak RE. Synthesis of atomically ordered AuCu and AuCu3 nanocrystals from bimetallic nanoparticle precursors. J Am Chem Soc. 2004; 126: 6667–6672.
[29]. Cheng G, Hight Walker AR. Synthesis and characterization of cobalt/gold bimetallic nanoparticles. J Magn Mater 2007; 311: 31–3.
[30]. Yuan L, Hu W, Zhang H, Chen L, Wang J, Wang Q. Cu5FeS4 nanoparticles with tunable plasmon resonances for efficient photothermal therapy of cancers. Front Bioeng Biotechnol. 2020; 8: 21.
[31]. Javed I, Peng G, Xing Y, Yu T, Zhao M, Kakinen A, Faridi A, Parish CL, Ding F, Davis TP, Ke PC, Lin S. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun. 2019; 10: 3780.
[32]. Parveen R, Shamsi TN, Fatima S. Nanoparticles-protein interaction: Role in protein aggregation and clinical implications. Int J Biol Macromol. 2017; 94: 386–395
[33]. Siddiqi MK, Malik S, Majid N, Alam P, Khan RH. Cytotoxic species in amyloid-associated diseases: oligomers or mature fibrils. Adv Protein Chem Struct Biol. 2019; 118: 333-369.
)